In last trading session, QuidelOrtho Corporation (NASDAQ:QDEL) saw 1.4 million shares changing hands with its beta currently measuring 0.13. Company’s recent per share price level of $33.03 trading at -$0.52 or -1.55% at ring of the bell on the day assigns it a market valuation of $2.23B. That closing price of QDEL’s stock is at a discount of -49.71% from its 52-week high price of $49.45 and is indicating a premium of 28.04% from its 52-week low price of $23.77.

For QuidelOrtho Corporation (QDEL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.90. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.01 in the current quarter.

QuidelOrtho Corporation (NASDAQ:QDEL) trade information

Upright in the red during last session for losing -1.55%, in the last five days QDEL remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $33.03 price level, adding 15.29% to its value on the day. QuidelOrtho Corporation’s shares saw a change of -25.86% in year-to-date performance and have moved -9.41% in past 5-day. QuidelOrtho Corporation (NASDAQ:QDEL) showed a performance of 24.36% in past 30-days.

Wall Street analysts have assigned a consensus price target of 110 to the stock, which implies a rise of 69.97% to its current value. Analysts have been projecting 50 as a low price target for the stock while placing it at a high target of 125. It follows that stock’s current price would drop -51.38% in reaching the projected high whereas dropping to the targeted low would mean a loss of -51.38% for stock’s current value.

QuidelOrtho Corporation (QDEL) estimates and forecasts

This year revenue growth is estimated to fall -2.47% from the last financial year’s standing.

8 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 612.36M for the same. And 8 analysts are in estimates of company making revenue of 694.96M in the next quarter. Company posted 637M and 727.1M of sales in current and next quarters respectively a year earlier.

In 2025, company’s earnings growth rate is likely to be around 28.99% while estimates for its earnings growth in next 5 years are of 31.81%.

QuidelOrtho Corporation (NASDAQ:QDEL)’s Major holders

CARLYLE GROUP INC. is the top institutional holder at QDEL for having 11.52 million shares of worth $382.72 million. And as of 2024-06-30, it was holding 17.1695 of the company’s outstanding shares.

The second largest institutional holder is T. ROWE PRICE INVESTMENT MANAGEMENT, INC., which was holding about 9.49 million shares on 2024-06-30. The number of shares represents firm’s hold over 14.1502 of outstanding shares, having a total worth of $315.42 million.

On the other hand, iShares Trust-iShares Core S&P Small-Cap ETF and T. Rowe Price Mid-Cap Growth Fund, Inc. are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025, the former fund manager was holding 4.08 shares of worth $134.61 million or 6.03% of the total outstanding shares. The later fund manager was in possession of 3.27 shares on Dec 31, 2024, making its stake of worth around $107.85 million in the company or a holder of 4.83% of company’s stock.